Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Haefeli

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
The Pharmacogenomics Journal|August 25, 2011
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort studyG Yimer, W Amogne, A Habtewold, et al.
Journal of Affective Disorders|December 19, 2018
Association of generalized anxiety symptoms and panic with health care costs in older age-Results from the ESTHER cohort studyJ K Hohls, B Wild, D Heider, et al.
BMC Geriatrics|July 17, 2021
Assessing the perspective of well-being of older patients with multiple morbidities by using the LAVA tool - a person-centered approachB Wild, V S Wurmbach, F Böhlen, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavirF Josephson, A Allqvist, M Janabi, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patientsE Ngaimisi, S Mugusi, O M Minzi, et al.
Clinical Pharmacology and Therapeutics|August 5, 2011
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosisE Ngaimisi, S Mugusi, O Minzi, et al.
Chemotherapy|November 24, 1999
Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trialL Haller, R Sossouhounto, I M Coulibaly, et al.
Clinical Pharmacology and Therapeutics|May 26, 2017
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir PharmacokineticsA Blank, A Eidam, M Haag, et al.
Schmerz (Berlin, Germany)|April 11, 2014
[Use and potential risks of over-the-counter analgesics]A Freytag, R Quinzler, M Freitag, et al.
Methods of Information in Medicine|March 20, 2013
Discussion of "Attitude of physicians towards automatic alerting in computerized physician order entry systems"D W Bates, M T Baysari, M Dugas, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
The Pharmacogenomics Journal|August 25, 2011
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort studyG Yimer, W Amogne, A Habtewold, et al.
Journal of Affective Disorders|December 19, 2018
Association of generalized anxiety symptoms and panic with health care costs in older age-Results from the ESTHER cohort studyJ K Hohls, B Wild, D Heider, et al.
BMC Geriatrics|July 17, 2021
Assessing the perspective of well-being of older patients with multiple morbidities by using the LAVA tool - a person-centered approachB Wild, V S Wurmbach, F Böhlen, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavirF Josephson, A Allqvist, M Janabi, et al.
Clinical Pharmacology and Therapeutics|October 1, 2010
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patientsE Ngaimisi, S Mugusi, O M Minzi, et al.
Clinical Pharmacology and Therapeutics|August 5, 2011
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosisE Ngaimisi, S Mugusi, O Minzi, et al.
Chemotherapy|November 24, 1999
Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trialL Haller, R Sossouhounto, I M Coulibaly, et al.
Clinical Pharmacology and Therapeutics|May 26, 2017
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir PharmacokineticsA Blank, A Eidam, M Haag, et al.
Schmerz (Berlin, Germany)|April 11, 2014
[Use and potential risks of over-the-counter analgesics]A Freytag, R Quinzler, M Freitag, et al.
Methods of Information in Medicine|March 20, 2013
Discussion of "Attitude of physicians towards automatic alerting in computerized physician order entry systems"D W Bates, M T Baysari, M Dugas, et al.
Pageof 14